Why is Colinz Labs falling/rising?

As of 10-Jul, Colinz Laboratories Ltd is experiencing a price increase, with its current price at Rs. 39.41, reflecting a rise of 0.77 or 1.99%. Today's performance is notable as the stock has outperformed its sector by 2.56% and has gained after 20 consecutive days of decline. However, it recently hit a new 52-week low of Rs. 37.87. Over the past week, the stock has declined by 5.88%, and it has seen a significant drop of 51.64% over the past year, indicating a troubling trend despite a slight increase in profits by 1%. The stock is trading at a discount compared to its peers, but it has weak long-term fundamentals, including a negative CAGR growth in net sales and a low return on equity, which may contribute to investor caution.
In the broader market context, the Sensex has remained relatively stable, with a minor decline of 0.06% over the past week. Colinz Laboratories' recent performance contrasts sharply with the benchmark, as it has underperformed significantly over various time frames, including a 43.51% decline year-to-date compared to a 6.46% increase in the Sensex. This disparity highlights the challenges Colinz Labs faces in regaining investor confidence, especially given its weak ability to service debt and low profitability metrics. The overall market conditions appear to be more favorable than those for Colinz Labs, which may explain the stock's ongoing volatility and recent attempts at recovery.